RxDoctor Payments Data

Lolanda McBride, NP

Nurse Practitioner · Denver, CONPI 1225222193

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Lilly USA, LLC at 52.9% of the total. Reporting peaked in 2022 at $9,801 and has fallen 89.2% since, to $1,063 in 2025. Among nurse practitioner clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$20,243in general payments, 2019–2025

Across 508 payments — averaging $39.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$11K
  • AbbVie$2K
  • Johnson & Johnson$1K
  • Pfizer$918
  • Novartis$794
  • Sun Pharmaceutical Industries Inc.$718
  • plus $4K from 19 others

What the payments were for

  • Speaking & faculty fees$7,80039%
  • Travel & lodging$1,3277%
  • Food & beverage$10,57752%
  • Education$5393%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,243 in reported general payments places this provider in the 95th percentile of 1,384 nurse practitioner providers in Colorado.

See all nurse practitioner providers in Colorado

Medicare billing

Part B allowed, 2024
$87,798
Medicare patients
315
Services billed
2,328

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate50$2,139
CiclopiroxCiclopirox Olamine68$2,045
Fluocinonide37$1,375
Triamcinolone Acetonide105$1,374
Clindamycin Phosphate36$1,338
Mupirocin149$1,135
Ammonium Lactate47$998
Metronidazole12$813
Ketoconazole40$505
Hydrocortisone79$498
Doxycycline Monohydrate30$447
Minocycline Hcl12$399
Cephalexin20$268
Nystatin14$222

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Denver

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →